Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia

BACKGROUND: Minimal residual disease detection in the bone marrow is usually performed in patients with acute myeloid leukemia undergoing one course of induction chemotherapy. To optimize the chemotherapy strategies, more practical and sensitive markers are needed to monitor the early treatment resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Cong, Kong, Qing-lei, Zhang, Yun-xiang, Weng, Xiang-qin, Wu, Jing, Sheng, Yan, Jiang, Chun-lei, Zhu, Yong-mei, Cao, Qi, Xiong, Shu-min, Li, Jun-min, Xi, Xiao-dong, Chen, Sai-juan, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431040/
https://www.ncbi.nlm.nih.gov/pubmed/25957890
http://dx.doi.org/10.1186/s13045-015-0145-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431040/
https://www.ncbi.nlm.nih.gov/pubmed/25957890
http://dx.doi.org/10.1186/s13045-015-0145-1

Ejemplares similares